Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

kTMP-Enhanced Arm Rehabilitation in Chronic Stroke (KULMINATE) Pilot

Official title: kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery

Run by Magnetic Tides · NCT07631078 · Data updated 2026-11-12

This pilot tests whether kTMP, a gentle brain stimulation method, can help improve arm and hand movement in adults with chronic stroke.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment6 (estimated)
SponsorMagnetic Tides
Industry-sponsored
Locations1 site (San Francisco, California)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedFebruary 28, 2027
Study endsAugust 2028
Registry record updatedSeptember 29, 2026
Trial IDNCT07631078 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-80 years with a history of ischemic or hemorrhagic stroke at least 12 months prior and a baseline FMA-UE score of 20-50, who can follow commands and show detectable motor-evoked potentials.

Probably not a fit

Patients without adequate motor-evoked potentials, significant cognitive or language impairments, or uncontrolled medical conditions may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 6-week, double-blind, randomized, sham-controlled pilot study. Participants with chronic stroke who have moderate arm weakness will be assigned to either kTMP plus simple motor tasks or sham kTMP with the same tasks. The study measures upper-limb movement outcomes at the end of treatment and during follow-up up to 6 months. Randomization occurs within one week of starting treatment, with sessions delivered three times per week. Outcomes include kinematic measures such as range of motion in the arm, hand, and fingers.

Why it matters

Potential benefit: If successful, participants may experience improved upper-limb function and greater potential for daily activities.

How similar studies have gone: Prior studies in similar neuromodulation approaches have shown feasibility and signals of benefit in motor recovery, but this exact kTMP approach is exploratory in chronic stroke.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Adults aged 18-80 years who have a history of an ischemic or hemorrhagic stroke ≥ 12 m prior to enrollment.
2. Fugl-Meyer Assessment: Upper Extremity (FMA UE) score 20-50.
3. Ability to communicate, understand, and give appropriate consent. Participants can follow two-step commands.
4. Motor evoked potentials in a hand muscle when stimulating ipsilesional cortex with suprathreshold single-pulse TMS (MEP positive).

Exclusion criteria:

1. Participants with moderate or severe cognitive impairment (MMSE \< 18).
2. Participants with sensory deficits FMA-S \< 6/12 (with proprioception \< 4/8).
3. Participants with severe apraxia (TULIA \< 5).
4. Language impairment or behavioral disorder that interferes with their ability to adhere to the protocol or to provide informed consent.
5. Individuals who have a serious uncontrolled medical condition, including but not limited to severe cardiovascular and cardiopulmonary disease.
6. Pregnancy or plans to become pregnant during the study period.
7. Botulinum toxin injections of the affected upper extremity within 3 months prior to onset of study.
8. Severe spasticity of the affected upper limb (Modified Ashworth ≥ 4).
9. Absolute contraindications related to non-invasive brain stimulation, including:

9a) History of seizures in the last 12 months while taking anti-epilepsy medication 9b) Presence of any metal implants in the head (excluding the mouth), such as cortical stimulators and DBS, clips, coils, shunts, stents or skull plates, cochlear implants 9c) Permanent eye liner or head tattoos 9d) Implanted electronics such as pacemakers, defibrillators, intrathecal baclofen pumps or vagus nerve stimulator 9e) History of experiencing a serious adverse event during a previous transcranial magnetic stimulation (TMS) session

Where it's running

  • UCSF Mission Bay- Sandler Neurosciences Center
    San Francisco, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.